Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Dubray CL, Sircar AD, Beau de Rochars VM, Bogus J, Direny AN, Ernest JR, Fayette CR, Goss CW, Hast M, O'Brian K, Pavilus GE, Sabin DF, Wiegand RE, Weil GJ, Lemoine JF. Dubray CL, et al. Among authors: goss cw. PLoS Negl Trop Dis. 2020 Jun 8;14(6):e0008298. doi: 10.1371/journal.pntd.0008298. eCollection 2020 Jun. PLoS Negl Trop Dis. 2020. PMID: 32511226 Free PMC article. Clinical Trial.
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
King CL, Suamani J, Sanuku N, Cheng YC, Satofan S, Mancuso B, Goss CW, Robinson LJ, Siba PM, Weil GJ, Kazura JW. King CL, et al. Among authors: goss cw. N Engl J Med. 2018 Nov 8;379(19):1801-1810. doi: 10.1056/NEJMoa1706854. N Engl J Med. 2018. PMID: 30403937 Free PMC article. Clinical Trial.
Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
Wanji S, Esum ME, Njouendou AJ, Mbeng AA, Chounna Ndongmo PW, Abong RA, Fru J, Fombad FF, Nchanji GT, Ngongeh G, Ngandjui NV, Enyong PI, Storey H, Curtis KC, Fischer K, Fauver JR, Lew D, Goss CW, Fischer PU. Wanji S, et al. Among authors: goss cw. PLoS Negl Trop Dis. 2019 Mar 8;13(3):e0007192. doi: 10.1371/journal.pntd.0007192. eCollection 2019 Mar. PLoS Negl Trop Dis. 2019. PMID: 30849120 Free PMC article.
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.
Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S; DOLF IDA Safety Study Group. Weil GJ, et al. Among authors: goss cw. PLoS Med. 2019 Jun 24;16(6):e1002839. doi: 10.1371/journal.pmed.1002839. eCollection 2019 Jun. PLoS Med. 2019. PMID: 31233507 Free PMC article. Clinical Trial.
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
Goss CW, O'Brian K, Dubray C, Fischer PU, Hardy M, Jambulingam P, King CL, Laman M, Lemoine JF, Robinson LJ, Samuela J, Subramanian S, Supali T, Weil GJ, Schechtman KB. Goss CW, et al. PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007541. doi: 10.1371/journal.pntd.0007541. eCollection 2019 Jul. PLoS Negl Trop Dis. 2019. PMID: 31314753 Free PMC article. Clinical Trial.
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Krentel A, Basker N, Beau de Rochars M, Bogus J, Dilliott D, Direny AN, Dubray C, Fischer PU, Ga AL, Goss CW, Hardy M, Howard C, Jambulingam P, King CL, Laman M, Lemoine JF, Mallya S, Robinson LJ, Samuela J, Schechtman KB, Steer AC, Supali T, Tavul L, Weil GJ. Krentel A, et al. Among authors: goss cw. PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009002. doi: 10.1371/journal.pntd.0009002. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33657090 Free PMC article. Clinical Trial.
99 results